Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Sep 27:2:198.
doi: 10.3389/fmicb.2011.00198. eCollection 2011.

Development of vaccines against burkholderia pseudomallei

Natasha Patel  1 , Laura Conejero, Melanie De Reynal, Anna Easton, Gregory J Bancroft, Richard W Titball
Affiliations

Development of vaccines against burkholderia pseudomallei

Natasha Patel et al. Front Microbiol. .

Abstract

Burkholderia pseudomallei is a Gram-negative bacterium which is the causative agent of melioidosis, a disease which carries a high mortality and morbidity rate in endemic areas of South East Asia and Northern Australia. At present there is no available human vaccine that protects against B. pseudomallei, and with the current limitations of antibiotic treatment, the development of new preventative and therapeutic interventions is crucial. This review considers the multiple elements of melioidosis vaccine research including: (i) the immune responses required for protective immunity, (ii) animal models available for preclinical testing of potential candidates, (iii) the different experimental vaccine strategies which are being pursued, and (iv) the obstacles and opportunities for eventual registration of a licensed vaccine in humans.

Keywords: Burkholderia pseudomallei; melioidosis; vaccines.

PubMed Disclaimer

References

    1. Adler N. R., Govan B., Cullinane M., Harper M., Adler B., Boyce J. D. (2009). The molecular and cellular basis of pathogenesis in melioidosis: how does Burkholderia pseudomallei cause disease? FEMS Microbiol. Rev. 33, 1079–1099 10.1111/j.1574-6976.2009.00189.x - DOI - PubMed
    1. Akira S., Uematsu S., Takeuchi O. (2006). Pathogen recognition and innate immunity. Cell 124, 783–801 10.1016/j.cell.2006.02.015 - DOI - PubMed
    1. Anuntagool N., Intachote P., Wuthiekanun V., White N. J., Sirisinha S. (1998). Lipopolysaccharide from nonvirulent Ara+Burkholderia pseudomallei isolates is immunologically indistinguishable from lipopolysaccharide from virulent Ara- clinical isolates. Clin. Diagn. Lab. Immunol. 5, 225–229 - PMC - PubMed
    1. Ashdown L. R., Guard R. W. (1984). The prevalence of human melioidosis in Northern Queensland. Am. J. Trop. Med. Hyg. 33, 474–478 - PubMed
    1. Atkins T., Prior R. G., Mack K., Russell P., Nelson M., Oyston P., Dougan G., Titball R. W. (2002a). A mutant of Burkholderia pseudomallei, auxotrophic in the branched chain amino acid biosynthetic pathway, is attenuated and protective in a murine model of melioidosis. Infect. Immun. 70, 5290–5294 10.1128/IAI.70.9.5290-5294.2002 - DOI - PMC - PubMed

LinkOut - more resources